+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnology Reagents: Global Strategic Business Report

  • PDF Icon

    Report

  • 232 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338910

Global Biotechnology Reagents Market to Reach $135.1 Billion by 2030

The global market for Biotechnology Reagents estimated at US$93.9 Billion in the year 2022, is projected to reach a revised size of US$135.1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Chromatography, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$40.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the In-vitro Diagnostics segment is readjusted to a revised 4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $25.6 Billion, While China is Forecast to Grow at 7.6% CAGR

The Biotechnology Reagents market in the U.S. is estimated at US$25.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$28.4 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$18.2 Billion by the year 2030.

Select Competitors (Total 267 Featured) -

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Biotechnology Reagents - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Biotechnology Reagents Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for Biotechnology Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 4: World 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 7: World 18-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for In-vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 10: World 18-Year Perspective for In-vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 13: World 18-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 15: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 16: World 18-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 19: World 18-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: USA Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 22: USA 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
CANADA
  • Table 23: Canada Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 24: Canada Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 25: Canada 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
JAPAN
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 26: Japan Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: Japan Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 28: Japan 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
CHINA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 29: China Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: China Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 31: China 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
EUROPE
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 32: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Biotechnology Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 34: Europe 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
  • Table 35: Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 37: Europe 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
FRANCE
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 38: France Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: France Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 40: France 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
GERMANY
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 41: Germany Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Germany Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 43: Germany 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
ITALY
  • Table 44: Italy Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Italy Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 46: Italy 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
UNITED KINGDOM
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 47: UK Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: UK Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 49: UK 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
SPAIN
  • Table 50: Spain Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Spain Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 52: Spain 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
RUSSIA
  • Table 53: Russia Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: Russia Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 55: Russia 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
REST OF EUROPE
  • Table 56: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: Rest of Europe Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 58: Rest of Europe 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
ASIA-PACIFIC
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 60: Asia-Pacific Historic Review for Biotechnology Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 61: Asia-Pacific 18-Year Perspective for Biotechnology Reagents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
  • Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Asia-Pacific Historic Review for Biotechnology Reagents by Technology - Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 64: Asia-Pacific 18-Year Perspective for Biotechnology Reagents by Technology - Percentage Breakdown of Value Sales for Chromatography, In-vitro Diagnostics, PCR, Cell Culture and Other Technologies for the Years 2012, 2023 & 2030
AUSTRALIA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Biotechnology Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Coporation
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fitzgerald Industries International
  • General Electric Company
  • Hoefer, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Olympus Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Promega Corporation
  • Quality Biological, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Europe N.V.
  • W. R. Grace & Co.
  • Waters Corporation

Table Information